15 years on siRNA delivery: beyond the state-of-the-art on inorganic nanoparticles for RNAi therapeutics

Conde, J., Ambrosone, A., Hernandez, Y., Tian, F., McCully, M., Berry, C. , Baptista, P. V., Tortiglione, C. and de la Fuente, J. M. (2015) 15 years on siRNA delivery: beyond the state-of-the-art on inorganic nanoparticles for RNAi therapeutics. Nano Today, 10(4), pp. 421-450. (doi: 10.1016/j.nantod.2015.06.008)

Full text not currently available from Enlighten.

Abstract

RNAi has always captivated scientists due to its tremendous power to modulate the phenotype of living organisms. This natural and powerful biological mechanism can now be harnessed to downregulate specific gene expression in diseased cells, opening up endless opportunities. Since most of the conventional siRNA delivery methods are limited by a narrow therapeutic index and significant side and off-target effects, we are now in the dawn of a new age in gene therapy driven by nanotechnology vehicles for RNAi therapeutics. Here, we outlook the “do's and dont's” of the inorganic RNAi nanomaterials developed in the last 15 years and the different strategies employed are compared and scrutinized, offering important suggestions for the next 15.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Berry, Dr Catherine
Authors: Conde, J., Ambrosone, A., Hernandez, Y., Tian, F., McCully, M., Berry, C., Baptista, P. V., Tortiglione, C., and de la Fuente, J. M.
College/School:College of Medical Veterinary and Life Sciences > Institute of Molecular Cell and Systems Biology
Journal Name:Nano Today
Publisher:Elsevier
ISSN:1748-0132
Published Online:08 August 2015

University Staff: Request a correction | Enlighten Editors: Update this record